NCT00059917View on ClinicalTrials.gov

Polyglutamate Camptothecin in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2003

Study Completion Date

May 31, 2005

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

polyglutamate camptothecin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00059917 - Polyglutamate Camptothecin in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter